Eaton Vance Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Eaton Vance Management's RMD Position: Q3 2022 in Review
Eaton Vance Management increased its ResMed (RMD) stake by 9.6% in Q3 2022, buying an estimated $2.42M and bringing the position to 121,700 shares worth $26.6M. The position accounts for 0.04% of the portfolio, ranked #385.
Eaton Vance Management first reported a position in RMD in Q2 2017 and has held it in 22 quarters since. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.
- Eaton Vance Management held 121,700 shares of ResMed worth $26.6M as of Q3 2022.
- Eaton Vance Management bought 10,625 ResMed shares in Q3 2022, an estimated $2.42M.
- ResMed made up 0.04% of Eaton Vance Management's portfolio in Q3 2022, its #385 holding.
- Eaton Vance Management first reported a position in ResMed in Q2 2017 and has held it in 22 quarters since.
- 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.